Stocktoria

RADNOSTIX INC INIS

RADNOSTIX INC (INIS) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $13.1M at a -6.9% net margin.

$0.10 high · $0.06 low · daily closes (~2y) · hover for date & price
23/100
Stocktoria Quality Score · grade D
3/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend yield · no dividend
-2.91
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
1 3 5 3 5 3 5 5 6 3 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$0.06 as of 2026-09-01 · +0% 1y
$0.06$0.1052-wk

Beneish M-score: -2.91 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$36M
Net margin 5y avg-4.1%
Return on equity 5y avg-14.4%
Beta1.17
Employees44
Revenue trend · last 9y · up

How it ranks in Manufacturing · percentile among 2036 companies

Piotroski Fstronger than 26%
Net marginstronger than 43%
Return on equitystronger than 40%
Revenue growthstronger than 20%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 3/9 tests passed

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
INISRADNOSTIX INC3/9——-6%
ELSEELECTRO SENSORS INC5/9—88.3—
CLIRClearSign Technologies Corp2/9———
FCUVFOCUS UNIVERSAL INC.2/9-1.6——
SENSSenseonics Holdings, Inc.6/9——+56.9%
SYPRSYPRIS SOLUTIONS INC2/9-2.92—-14.5%
HURCHURCO COMPANIES INC4/99.02—-4.3%

All Manufacturing companies →

About RADNOSTIX INC

Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, and research applications. The Cobalt Products segment produces cobalt-60 products and services, the fabrication of cobalt-60 sealed sources for radiation therapy, industrial and medical applications, and recycling of expended cobalt-60 sources. The Calibration & Reference Products segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, cylinder phantoms, rod sources, line sources, flexible and rigid rulers, spot markers, pen point markers, and various specialty design items. The Medical Devices segment develops EasyFill Automated Capsule System, a robotic lab device. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. The company was formerly known as International Isotopes Inc. and changed its name to Radnostix, Inc. in December 2025. Radnostix, Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.

FAQ

Is INIS financially healthy?

RADNOSTIX INC's Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).

Does INIS pay a dividend?

No, RADNOSTIX INC does not currently pay a dividend.

How profitable is INIS?

In FY2025, RADNOSTIX INC had a net margin of -6.9% and a return on equity of -24.6%.

Is INIS a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on RADNOSTIX INC: a Piotroski F-score of 3/9. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.